Related Experiment Video

Updated: Aug 14, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

The impact of JNC-VI guidelines on treatment recommendations in the US population

Paul Muntner1, Jiang He, Edward J Roccella

  • 1Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, La 70112, USA. pmuntner@tulane.edu

Hypertension (Dallas, Tex. : 1979)
|April 23, 2002
PubMed

Insights

The JNC-VI guidelines now incorporate cardiovascular disease risk alongside blood pressure for treatment decisions. This approach identifies more Americans for aggressive risk reduction, including those with high-normal blood pressure.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Previous Joint National Committee (JNC) guidelines primarily focused on blood pressure levels for hypertension treatment.
  • The sixth report of the Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure (JNC-VI) introduced cardiovascular disease (CVD) risk assessment.
  • Integrating CVD risk into treatment decisions aims to refine patient stratification and intervention strategies.

Purpose of the Study:

  • To estimate the impact of JNC-VI's cardiovascular disease risk-based treatment recommendations on the US population.
  • To analyze how incorporating CVD risk factors influences hypertension management strategies.
  • To identify patient subgroups benefiting from JNC-VI's updated guidelines for aggressive risk reduction.

Main Methods:

  • Utilized data from 16,527 participants in the Third National Health and Nutrition Examination Survey (NHANES III).
  • Stratified the US population (≥20 years) based on blood pressure levels and CVD risk factors according to JNC-VI criteria.
  • Categorized individuals into risk groups A (no CVD risk factors/disease), B (≥1 major risk factor), and C (diabetes, clinical CVD, target organ damage).

Main Results:

  • 36% of the US adult population (62 million) had high-normal blood pressure or greater, or were on medication.
  • Within this group, 5.1% were in risk group A, 66.3% in risk group B, and 28.6% in risk group C.
  • 11% (7.0 million) with high-normal blood pressure or stage-1 hypertension and at least one risk factor (group C) were not on medication, now recommended for drug therapy by JNC-VI.

Conclusions:

  • JNC-VI guidelines refine cardiovascular risk assessment for hypertension management.
  • The updated guidelines enable more Americans, including those with high-normal blood pressure, to be considered for aggressive risk reduction.
  • JNC-VI emphasizes lifestyle modification and, for specific high-risk individuals, initial drug therapy, enhancing CVD prevention efforts.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Related Concept Videos

Nursing Interventions II: Selecting and Classifying the Nursing Interventions01:29

Nursing Interventions II: Selecting and Classifying the Nursing Interventions

Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...